Brukinsa 160 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV8T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,720
Award facts
- Contract value 100% obligated
- $16,720.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on February 2, 2026, for the supply of BRUKINSA 160 MG tablets (60-count units) with a ceiling value of $16,720.28. This is a firm fixed-price delivery order with an ultimate completion date of February 24, 2026, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (UEI: NWEGNLYTBDW4), a major pharmaceutical distributor and healthcare solutions provider that serves critical federal medical procurement needs across multiple therapeutic domains. The parent company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. Both entities have established track records of supplying pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through open and competitive procurements.
Quick answers
Who was awarded contract SPE2DR26FQV8T?
SPE2DR26FQV8T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FQV8T worth?
The government has obligated $16,720 on SPE2DR26FQV8T.
Is contract SPE2DR26FQV8T an order under another contract?
Yes. SPE2DR26FQV8T is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV8T competed?
The extent of competition for SPE2DR26FQV8T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award